147 related articles for article (PubMed ID: 11815410)
1. Waf-1 (p21) and p53 polymorphisms in breast cancer.
Keshava C; Frye BL; Wolff MS; McCanlies EC; Weston A
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):127-30. PubMed ID: 11815410
[TBL] [Abstract][Full Text] [Related]
2. No point mutation but a codon 31ser-->arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese.
Sun Y; Hildesheim A; Li H; Li Y; Chen JY; Cheng YJ; Hayes RB; Rothman N; Bi WF; Cao Y
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):261-7. PubMed ID: 7606201
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
4. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
Roh JW; Kim JW; Park NH; Song YS; Park IA; Park SY; Kang SB; Lee HP
Gynecol Oncol; 2004 May; 93(2):499-505. PubMed ID: 15099969
[TBL] [Abstract][Full Text] [Related]
5. p53 haplotype determination in breast cancer.
Weston A; Pan CF; Ksieski HB; Wallenstein S; Berkowitz GS; Tartter PI; Bleiweiss IJ; Brower ST; Senie RT; Wolff MS
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):105-12. PubMed ID: 9037561
[TBL] [Abstract][Full Text] [Related]
6. CYP17 genotype and breast cancer risk.
Weston A; Pan CF; Bleiweiss IJ; Ksieski HB; Roy N; Maloney N; Wolff MS
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):941-4. PubMed ID: 9796640
[TBL] [Abstract][Full Text] [Related]
7. Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in Taiwan.
Wu MT; Chen MC; Wu DC
Cancer Lett; 2004 Mar; 205(1):61-8. PubMed ID: 15036662
[TBL] [Abstract][Full Text] [Related]
8. p21(waf) correlates with DNA replication but not with prognosis in invasive breast cancer.
Göhring UJ; Bersch A; Becker M; Neuhaus W; Schöndorf T
J Clin Pathol; 2001 Nov; 54(11):866-70. PubMed ID: 11684722
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study.
Mechanic LE; Millikan RC; Player J; de Cotret AR; Winkel S; Worley K; Heard K; Heard K; Tse CK; Keku T
Carcinogenesis; 2006 Jul; 27(7):1377-85. PubMed ID: 16399771
[TBL] [Abstract][Full Text] [Related]
10. The codon 31 polymorphism of the p53-inducible gene p21 shows distinct differences between major ethnic groups.
Birgander R; Själander A; Saha N; Spitsyn V; Beckman L; Beckman G
Hum Hered; 1996; 46(3):148-54. PubMed ID: 8860009
[TBL] [Abstract][Full Text] [Related]
11. P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21.
Su L; Sai Y; Fan R; Thurston SW; Miller DP; Zhou W; Wain JC; Lynch TJ; Liu G; Christiani DC
Lung Cancer; 2003 Jun; 40(3):259-66. PubMed ID: 12781424
[TBL] [Abstract][Full Text] [Related]
12. p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity.
Wu X; Zhao H; Amos CI; Shete S; Makan N; Hong WK; Kadlubar FF; Spitz MR
J Natl Cancer Inst; 2002 May; 94(9):681-90. PubMed ID: 11983757
[TBL] [Abstract][Full Text] [Related]
13. Quantitative p21(waf-1)/p53 immunohistochemical analysis defines groups of primary invasive breast carcinomas with different prognostic indicators.
Ceccarelli C; Santini D; Chieco P; Lanciotti C; Taffurelli M; Paladini G; Marrano D
Int J Cancer; 2001 Mar; 95(2):128-34. PubMed ID: 11241324
[TBL] [Abstract][Full Text] [Related]
14. Lack of evidence of association of p21WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan.
Shih CM; Lin PT; Wang HC; Huang WC; Wang YC
Jpn J Cancer Res; 2000 Jan; 91(1):9-15. PubMed ID: 10744039
[TBL] [Abstract][Full Text] [Related]
15. Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study.
Connor AE; Baumgartner RN; Baumgartner KB; Kerber RA; Pinkston C; John EM; Torres-Mejia G; Hines L; Giuliano A; Wolff RK; Slattery ML
Breast Cancer Res Treat; 2012 Nov; 136(2):593-602. PubMed ID: 23085767
[TBL] [Abstract][Full Text] [Related]
16. Generalizability of Polygenic Risk Scores for Breast Cancer Among Women With European, African, and Latinx Ancestry.
Liu C; Zeinomar N; Chung WK; Kiryluk K; Gharavi AG; Hripcsak G; Crew KD; Shang N; Khan A; Fasel D; Manolio TA; Jarvik GP; Rowley R; Justice AE; Rahm AK; Fullerton SM; Smoller JW; Larson EB; Crane PK; Dikilitas O; Wiesner GL; Bick AG; Terry MB; Weng C
JAMA Netw Open; 2021 Aug; 4(8):e2119084. PubMed ID: 34347061
[TBL] [Abstract][Full Text] [Related]
17. Genetic ancestry and risk factors for breast cancer among Latinas in the San Francisco Bay Area.
Ziv E; John EM; Choudhry S; Kho J; Lorizio W; Perez-Stable EJ; Burchard EG
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1878-85. PubMed ID: 17035394
[TBL] [Abstract][Full Text] [Related]
18. No association of p53 codon 72 and p21 codon 31 polymorphisms in Taiwan Chinese patients with pterygium.
Tsai YY; Tsai YY; Cheng YW; Lee H; Tseng SH; Tsai CH; Tsai FJ
Br J Ophthalmol; 2004 Jul; 88(7):975-6. PubMed ID: 15205257
[No Abstract] [Full Text] [Related]
19. Associations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer.
Powell BL; van Staveren IL; Roosken P; Grieu F; Berns EM; Iacopetta B
Carcinogenesis; 2002 Feb; 23(2):311-5. PubMed ID: 11872638
[TBL] [Abstract][Full Text] [Related]
20. p21(WAF-1/CIP-1), a downstream regulator of functional p53 loss, in transitional cell carcinoma of urothelium.
Ozdemir E; Kakehi Y; Yoshida O
Eur Urol; 2000 Aug; 38(2):230-4. PubMed ID: 10895017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
